Rooted Wealth Advisors Inc. Boosts Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Rooted Wealth Advisors Inc. raised its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 16.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 15,786 shares of the exchange traded fund’s stock after buying an additional 2,199 shares during the quarter. Rooted Wealth Advisors Inc.’s holdings in SPDR S&P Biotech ETF were worth $1,466,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in the stock. Golden State Wealth Management LLC bought a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at $29,000. Avior Wealth Management LLC increased its stake in SPDR S&P Biotech ETF by 393.6% during the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after purchasing an additional 307 shares in the last quarter. Tidemark LLC increased its stake in SPDR S&P Biotech ETF by 101.5% during the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after purchasing an additional 199 shares in the last quarter. Quintet Private Bank Europe S.A. purchased a new position in SPDR S&P Biotech ETF in the third quarter worth about $40,000. Finally, Howe & Rusling Inc. bought a new position in shares of SPDR S&P Biotech ETF in the third quarter worth approximately $49,000.

SPDR S&P Biotech ETF Stock Up 0.9 %

NYSEARCA:XBI opened at $90.77 on Friday. The stock has a market cap of $6.92 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. The company’s 50 day moving average price is $91.92 and its 200-day moving average price is $96.21. SPDR S&P Biotech ETF has a 52 week low of $81.14 and a 52 week high of $105.47.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.